Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Basireh Naseri Boroujeni"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Evaluation of the Mechanical Properties and Drug Permeability of Chitosan/Eudragit RL Composite Film
Maryam Kouchak, Somayeh Handali, Basireh Naseri Boroujeni
Osong Public Health Res Perspect. 2015;6(1):14-19.   Published online February 28, 2015
DOI: https://doi.org/10.1016/j.phrp.2014.12.001
  • 1,379 View
  • 15 Download
  • 21 Citations
AbstractAbstract PDF
Objectives
The aim of this study was to design and evaluate a chitosan-based film that has properties required for successful wound dressing, and can control drug penetration and maintenance time in the location.
Methods
Several formulations of a film containing chitosan (3%) and different concentrations of Eudragit RL (0.5%, 1%, and 1.5%) were prepared using the casting/solvent evaporating technique. Mechanical properties, water vapor transmission rate (WVTR), oxygen permeability, water uptake, and nitrofurazone permeability through the films were investigated.
Results
The study results showed that by increasing the Eudragit RL content of composite films, their thickness and tensile strength were enhanced, while their elongation was decreased. No significant difference was observed between the oxygen permeability, WVTR, and water uptake results of pure chitosan films and different composite films containing Eudragit RL. Nitrofurazone permeability of chitosan films was increased by the inclusion of Eudragit RL in composite films, while by increasing the concentration of Eudragit RL, the permeation rate of drug was decreased.
Conclusion
In conclusion, addition of Eudragit RL can improve mechanical properties of chitosan films without any undesirable effect on their water uptake, oxygen permeability, and WVTR qualities. The permeation rate of drugs through the composite films can be modified by changing Eudragit RL/chitosan ratio.

PHRP : Osong Public Health and Research Perspectives